Cargando…
The identification of a novel orally available ferroptosis inducer for the treatment of clear cell renal carcinoma
BACKGROUND: Background: Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, is typically initiated by inactivation of the von Hippel Lindau (VHL) gene resulting in constitutive activation of the hypoxia inducible factors, HIF-1α and HIF-2α. HIF-2α is a central driver of k...
Autor principal: | Koh, Mei Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445565/ http://dx.doi.org/10.1093/oncolo/oyad216.015 |
Ejemplares similares
-
Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021) -
Characterization of the Cellular Origin and Oncogenic Mechanisms of Chromophobe Renal Cell Carcinoma (ChRCC) and Renal Oncocytic Neoplasms
por: Labaki, Chris, et al.
Publicado: (2023) -
ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma
por: Green, Yangsook Song, et al.
Publicado: (2022) -
Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation (SD) of renal cell carcinoma (RCC)
por: El Zarif, Talal, et al.
Publicado: (2023) -
Dissection of tumor-intrinsic and tumor-extrinsic features of MiT/TFE translocation renal cell carcinoma via single-cell RNA sequencing
por: Konda, Prathyusha, et al.
Publicado: (2023)